Search - tctmd.com

Displaying 961 - 980 of 1203

Sort: Relevancy | Date

Presentation TCT 2012

Management of Diffuse Restenosis After DES

Presenter: Alaide Chieffo

October 24, 2012

Presentation TCT 2012

Case 2: IVUS Guided Diagnosis and Therapy of In-Stent Restenosis

Presenter: Ricardo Costa

October 24, 2012

News Industry News

Second Generation Drug-Eluting Stents are Safe and Effective in Treatment of Left Main Coronary Artery Disease

October 24, 2012

News Conference News TCT 2012

Promising Outlook for Bioabsorbable Scaffolds, Polymers in Next-Generation Stents

October 24, 2012

News Industry News

Nitinol Stent Performs Better Than Balloon Angioplasty Alone in Treating Lesions of the Popliteal Artery

October 24, 2012

News Conference News TCT 2012

ISAR-LEFT MAIN 2: Second-Generation DES Effective in Left Main CAD

October 24, 2012

News Conference News TCT 2012

Experts Discuss Need for Development of Next-Generation DES, Insights from Pathology

October 24, 2012

News Conference News TCT 2012

DEBATE-SFA Favors Predilatation with Drug-Eluting Balloon Before BMS

October 24, 2012

News Conference News TCT 2012

STOP-IC: Cilostazol Improves Angiographic Restenosis for Femoropopliteal Lesions After Stenting

October 23, 2012

Presentation TCT 2012

In-Stent Restenosis: Mechanisms, Predictors, and Treatment

Presenter: Roxana Mehran

October 23, 2012

News Conference News TCT 2012

DES: The Year in Review

October 23, 2012

Presentation TCT 2012

What Can Advanced Stent Imaging Tell Us About In-Stent Restenosis, Plaque Prolapse, and Design of Future Stents?

Presenter: Mark Wholey

October 22, 2012

Presentation TCT 2012

Imaging Studies of Late Restenosis and/or Stent Thrombosis: Is Neoatherosclerosis the Final Common Pathway of DES Failure?

Presenter: Soo-Jin Kang

October 22, 2012

Presentation TCT 2012

Frequency and Management of Left Main Restenosis

Presenter: Bernhard Reimers

October 22, 2012

Presentation TCT 2012

Drug-Coated Balloons for SFA In-Stent Restenosis: A Simple Solution for a Tenacious Problem?

Presenter: Eugenio Stabile

October 22, 2012

Presentation TCT 2012

DES Restenosis: Treatment Options and Recurrent Event Rates

Presenter: Alaide Chieffo

October 22, 2012

Presentation TCT 2012

Case Presentation (with Discussion): Recurrent DES Restenosis

Presenter: Simon Walsh

October 22, 2012

Presentation TCT 2012

Adventitial Injection for SFA Restenosis: Results of an Exploratory Study

Presenter: Christopher Owens

October 22, 2012

News Conference News TCT 2012

Second-Generation DES Safer, More Effective Than BMS in STEMI at 1 Year

October 22, 2012

Presentation TCT 2012

Restenosis After Coronary Stenting in 10,004 Patients with Follow-up Angiography

Presenter: Salvatore Cassese

October 22, 2012

Advertisement

Management of Diffuse Restenosis After DES

Case 2: IVUS Guided Diagnosis and Therapy of In-Stent Restenosis

Second Generation Drug-Eluting Stents are Safe and Effective in Treatment of Left Main Coronary Artery Disease

Promising Outlook for Bioabsorbable Scaffolds, Polymers in Next-Generation Stents

Nitinol Stent Performs Better Than Balloon Angioplasty Alone in Treating Lesions of the Popliteal Artery

ISAR-LEFT MAIN 2: Second-Generation DES Effective in Left Main CAD

Experts Discuss Need for Development of Next-Generation DES, Insights from Pathology

DEBATE-SFA Favors Predilatation with Drug-Eluting Balloon Before BMS

STOP-IC: Cilostazol Improves Angiographic Restenosis for Femoropopliteal Lesions After Stenting

In-Stent Restenosis: Mechanisms, Predictors, and Treatment

DES: The Year in Review

What Can Advanced Stent Imaging Tell Us About In-Stent Restenosis, Plaque Prolapse, and Design of Future Stents?

Imaging Studies of Late Restenosis and/or Stent Thrombosis: Is Neoatherosclerosis the Final Common Pathway of DES Failure?

Frequency and Management of Left Main Restenosis

Drug-Coated Balloons for SFA In-Stent Restenosis: A Simple Solution for a Tenacious Problem?

DES Restenosis: Treatment Options and Recurrent Event Rates

Case Presentation (with Discussion): Recurrent DES Restenosis

Adventitial Injection for SFA Restenosis: Results of an Exploratory Study

Second-Generation DES Safer, More Effective Than BMS in STEMI at 1 Year

Restenosis After Coronary Stenting in 10,004 Patients with Follow-up Angiography

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content